FIGURE 2

![FIGURE 2: Hair density and shedding rate measurements at baseline and post-treatment in telogen effluvium patients using 5% topical minoxidil.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411807/bin/JDE-52-1351-g003.jpg)

> Source: Manabu Ohyama et al. "Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open-Label Sin." *The Journal of dermatology*, 2025. PMID: [40599040](https://pubmed.ncbi.nlm.nih.gov/40599040/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411807/bin/JDE-52-1351-g003.jpg" alt="Hair density and shedding rate measurements at baseline and post-treatment in telogen effluvium patients using 5% topical minoxidil." />
  <figcaption>FIGURE 2. Hair density and shedding rate measurements at baseline and post-treatment in telogen effluvium patients using 5% topical minoxidil.<br>  Source: Manabu Ohyama et al. "Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open-Label Sin." <em>The Journal of dermatology</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40599040/">40599040</a></figcaption>
</figure>